Furthermore, since higher myeloperoxidase levels were reported in Apo−/− mice,27 we can postulate that C2238/αANP may, at least in part, associate to higher myeloperoxidase levels, as previously reported in coronary artery disease patients,4 through its ability to lower ApoE gene expression. This evidence concerns the gene MPO and coronary artery disorder.